Page 9 - Pharmaceutical Solution for Pharma Analysis
P. 9

Application   No. C155
    News



            „  Estimate of phospholipids by SimLipid           „  Phospholipids in four tissue samples
            Based on the PIS and NLS analysis results shown in   Figure 3 shows the peak intensities “Total Abundance”
            Figure 1, we conducted a database search using     of phospholipids confirmed in all tissue samples
            SimLipid software to estimate the phospholipids of   among the PLs estimated in each tissue as a result of
            each detected peak. First the data acquired by LCMS-  the database search. From Figure 3, we can see the
            8060 was read directly by SimLipid software and then   phospholipids characteristic to each tissue. For
            the peak intensity detected by PIS and NLS analysis   example, PC(32:0) is known as the main component of
            were calculated for each sample. We conducted a    pulmonary surfactant which has the function of
            database search on the basis of a tolerance,       decreasing the surface tension of the alveoli, and
            presence/absence of adduct ion and selection of    PC(32:1) is also contained a lot. It is also known that
            product ion (fatty acids or head groups) for the set   there are many phosphatidylcholines including
            mass value. In SimLipid software, thousands of     palmitic acid (16:0) and oleic acid (18:1) in the cerebral
            phospholipids are registered in the database and the   cortex of the brain. Furthermore, we can see that
            peaks detected under the preset conditions are     many phospholipids are remarkably contained in the
            compared with the database. Figure 2 shows an      liver tissue in this result.
            example of database search of lung tissue analysis
            results. Here information about each phospholipid
            class and the total number of carbon chain and     By the database search using SimLipid software as
            double bonds of fatty acids for the corresponding   shown here, it enables to estimate a kind of
            peak, are estimated as a result of database search.     phospholipid contained in the sample from enormous
            The integrated intensity of the corresponding peak   phospholipids.
            “Total Abundance” is displayed in Figure 2 (n=4).



















                                            Example of database search by SimLipid (Lung tissue)


               7.E+08                                                            4.E+06
               6.E+08                                                            3.E+06
               5.E+08                                                            3.E+06
               4.E+08                                                            2.E+06

               3.E+08                                                            2.E+06
               2.E+08                                                            1.E+06
               1.E+08                                                            5.E+05
               0.E+00                                                            0.E+00
                     PC(32:0) PC(32:1) PC(34:1) PC(36:2) PC(36:4) PC(38:4) SM(40:1) SM(40:3) SM(42:3)  PI(38:3) PI(38:4) PS(36:4)

                                   Brain  Spleen  Lung  Liver                      Brain  Spleen  Lung  Liver

                                          “Total Abundance” of phospholipids in four tissue samples

                                                                                                      First Edition: Apr. 2017
                                             For Research Use Only. Not for use in diagnostic procedure.
                                             This publication may contain references to products that are not available in your country. Please contact us to check the availability of these
                                             products in your country.

                                             The content of this publication shall not be reproduced, altered or sold for any commercial purpose without the written approval of Shimadzu.
                                             Company names, product/service names and logos used in this publication are trademarks and trade names of Shimadzu Corporation or its
                                             affiliates, whether or not they are used with trademark symbol “TM” or “£”. Third-party trademarks and trade names may be used in this
                                             publication to refer to either the entities or their products/services. Shimadzu disclaims any proprietary interest in trademarks and trade names
     www.shimadzu.com/an/                    other than its own.

                                             The information contained herein is provided to you "as is" without warranty of any kind including without limitation warranties as to its
                                             accuracy or completeness. Shimadzu does not assume any responsibility or liability for any damage, whether direct or indirect, relating to the
                                             use of this publication. This publication is based upon the information available to Shimadzu on or before the date of publication, and subject
                                             to change without notice.
                                                                                                  © Shimadzu Corporation, 2017
   4   5   6   7   8   9   10   11   12   13   14